Stock Code: 002424 Stock Abbreviation: ST Bai Ling Announcement Number: 2026-034 Guizhou Bai Ling Pharmaceutical Group Co., Ltd. Announcement on the Appointment of the Secretary of the Board of Directors
The Company and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, and that there are no false records, misleading statements, or major omissions.
Guizhou Bai Ling Pharmaceutical Group Co., Ltd. (hereinafter referred to as the "Company") held the 26th meeting of the Sixth Board of Directors on May 12, 2026. The meeting deliberated and approved the "Proposal on the Appointment of the Secretary of the Board of Directors." After the qualification review by the Board's Nomination Committee, the Board agreed to appoint Mr. Li Zejun as the Secretary of the Board of Directors. His term of office shall commence from the date of approval of this Board meeting and end on the expiration of the term of the Sixth Board of Directors. From the date Mr. Li Zejun assumes the position of Secretary of the Board of Directors, Mr. Chen Pei will no longer act as the interim Secretary of the Board of Directors.
Mr. Li Zejun has obtained the qualification certificate for Secretary of the Board of Directors issued by the Shenzhen Stock Exchange. He possesses the professional knowledge and work experience necessary to perform the duties of the Secretary of the Board of Directors. His qualifications meet the requirements of laws and regulations such as the "Company Law" and the "Stock Listing Rules of the Shenzhen Stock Exchange," and there are no circumstances that make him unsuitable for the position of Secretary of the Board of Directors. Mr. Li Zejun's resume is attached.